HCV对HIV/HCV共感染患者病情进展的影响

刘金花; 赵艳; 孙焕芹; 刘宁; 乔桂芳; 王子康; 徐杰; 李昂; 张永宏

doi:10.3969/j.issn.1001-5256.2014.06.006

HCV对HIV/HCV共感染患者病情进展的影响

DOI: 10.3969/j.issn.1001-5256.2014.06.006

1. 首都医科大学附属北京佑安医院生物医学信息中心
2. 首都医科大学附属北京佑安医院感染与免疫研究中心

基金项目:

国家自然科学基金(81271842)；北京市自然科学基金(7132098)；北京市科技计划项目(D131100005313004);北京市科技计划项目(D131100005315005)；

详细信息

中图分类号: R512.91;R512.63
计量
- 文章访问数: 3093
- HTML全文浏览量: 7
- PDF下载量: 807
- 被引次数: 0
出版历程
- 收稿日期: 2014-01-28
- 出版日期: 2014-06-20

Effect of HCV on disease progression in patients with HIV /HCV coinfection

Biomedical Information Center & Center for Infection and Immunity, Beijing YouAn Hospital, Capital Medical University

Research funding:

摘要

摘要: 目的探讨HCV对HIV/HCV共感染病情进展的影响。方法研究对象为2012年8月到北京佑安医院随访的HIV/HCV共感染者29例及HIV单独感染者20例。两组患者年龄、性别及HIV感染时间及感染方式、感染的HIV病毒亚型均具有可比性。外周血生化指标检测并采用瞬时弹性扫描仪FibroScan评估肝脏功能及纤维化程度,运用流式细胞技术检测外周血CD4+T、CD8+T细胞绝对计数。两组计量资料比较采用t检验,计数资料比较采用χ2检验。结果 HIV/HCV共感染组ALT、AST及TBil水平分别为（76.16±81.25）U/L、（87.66±71.32）U/L、（14.21±9.56）μmol/L,明显高于HIV单独感染组[（27.74±20.63）U/L、（45.65±16.95）U/L、（10.26±3.22）μmol/L],差异具有统计学意义（P值分别为0.004、0.005及0.046）。与HIV单独感染组相比,HIV/HCV共感染组Stiffness指数有升高的趋势,但差异无统计学意义（t=1.889,P=0.080）。HIV/HCV共感染组HIV病毒载量（拷贝/ml）的对数值为3...
- HIV /
- 丙型肝炎病毒 /
- 共感染
Abstract: Objective To analyze the effect of hepatitis C virus ( HCV) on disease progression in patients with human immunodeficiency virus ( HIV) /HCV coinfection. Methods Twenty- nine patients with HIV /HCV coinfection and 20 patients with HIV infection alone, who visited Beijing YouAn hospital for follow- up in August 2012, were enrolled. The two groups of patients were matched for age, sex, time and route of HIV infection, and HIV subtypes. The liver function and fibrosis were evaluated by biochemical testing of peripheral blood and FibroScan. CD4+and CD8+T cell counts were determined by flow cytometry. Results The levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin for the HIV /HCV coinfection group were 76. 16 ± 81. 25 U /L, 87. 66 ± 71. 32 U /L, and 14. 21 ± 9. 56μmol/L, respectively, significantly higher than those for the HIV infection group ( 27. 74 ±20. 63 U/L, 45. 65 ±16. 95 U/L, and 10. 26 ±3. 22 μmol /L) ( P = 0. 004, 0. 005, and 0. 046) . Compared with the HIV infection group, the HIV /HCV coinfection group had a nonsignificantly increased liver stiffness ( t = 1. 889, P = 0. 080) , a significantly higher viral load ( 3. 66 ± 0. 97 lg copies /ml vs 3. 02 ± 0. 90 lg copies /ml, t = 2. 251, P = 0. 030) , significantly lower CD4+T cell count and CD4+/CD8+ratio ( 374. 25 ± 185. 48 cells /μl vs 496. 45 ±230. 98 cells /μl, P = 0. 048; 0. 33 ± 0. 17 vs 0. 46 ± 0. 27, P = 0. 043) , and a nonsignificantly higher incidence of AIDS ( 27. 59% vs5. 00%, P = 0. 063) . Conclusion HCV exacerbates liver damage, enhances HIV replication, increases the impairment of immune function in patients with HIV /HCV coinfection, so it can accelerate the disease progression in these patients.
- HIV /
- hepatitis C virus /
- coinfection

HTML全文

参考文献(16)

[1]LIN W, WEINBERG EM, CHUNG RT.Pathogenesis of accelerated fibrosis in HIV/HCV co-infection[J].J Infect Dis, 2013, 207 (Suppl 1) :s13-s18.

[2]NEUKAM K, GARCIA-REY S, CIFUENTES C, et al.HIVcoinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection[J].Antiviral Res, 2012, 95 (3) :212-215.

[3]MOCROFT AJ, LUNDGREN JD, d'ARMINIO MONFORTE A, et al.Survival of AIDS patients according to type of AIDS-defining event.The AIDS in Europe Study Group[J].Int J Epidemiol, 1997, 26 (2) :400-407.

[4]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 20 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 20 (4) :197-203.

[5]SUN HQ, HUANG Q, CAI WP, et al.Mutual influence of human immunodeficiency virus and hepatitis C virus coinfection on disease processes[J].J Med Res, 2012, 41 (3) :3-5, 86. (in Chinese) 孙洪清, 黄琴, 蔡卫平, 等.人类免疫缺陷病毒和丙型肝炎病毒合并感染对疾病进程的相互影响[J].医学研究杂志, 2012, 41 (3) :3-5, 86.

[6]MAIER I, WU GY.Hepatitis C and HIV co-infection:a review[J].World J Gastroenterol, 2002, 8 (4) :577-579.

[7]LUO DD.The lecture of infectious diseases[M].Beijing:People's Medical Publishing House, 2002:114-122. (in Chinese) 罗端德.传染病讲座[M].北京:人民卫生出版社, 2002:114-122.

[8]LIU Z, XING WG, ZHANG YH, et al.Study on the epidemiology and HCV genotype distribution of HIV/HCV co-infection among HIV infected blood donors in China[J].Chin J Hepatol, 2006, 14 (6) :464-465. (in Chinese) 刘震, 邢文革, 张永宏, 等.既往有偿献血浆人群中艾滋病毒与丙型肝炎病毒共感染研究[J].中华肝脏病杂志, 2006, 14 (6) :464-465.

[9]HERNANDEZ MD, SHERMAN KE.HIV/hepatitis C coinfection natural history and disease progression[J].Curr Opin HIV AIDS, 2011, 6 (6) :478-482.

[10]SINGAL AK, ANAND BS.Management of hepatitis C virus infection in HIV/HCV co-infected patients:clinical review[J].World J Gastroenterol, 2009, 15 (30) :3713-3724.

[11]LPEZ-DIGUEZ M, MONTES ML, PASCUAL-PAREJA JF, et al.The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients[J].AIDS, 2011, 25 (7) :899-904.

[12]SUN HQ, HUANG Q, SHEN F, et al.Effects of different antiHIV therapies on progression of hepatitis C in HCV/HIV-coinfected patients[J].J Clin Hepatol, 2013, 29 (11) :835-838. (in Chinese) 孙洪清, 黄琴, 沈芳, 等.不同抗HIV治疗方案对HCV与HIV合并感染者丙型肝炎疾病进展的影响[J].临床肝胆病杂志, 2013, 29 (11) :835-838.

[13]ROCKSTROH JK, MOCROFT A, SORIANO V, et al.Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy[J].J Infect Dis, 2005, 192 (6) :992-1002.

[14]AL-HARTHI L, VORIS J, DU W, et al.Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapymediated immune responses in HCV/HIV coinfected women:role of HCV on expression of primed/memory T cells[J].J Infect Dis, 2006, 193 (9) :1202-1210.

[15]MILLER MF, HALEY C, KOZIEL MJ, et al.Impact of hepatitis C virus on immune restoration in HIV infected patients who start highly active antiretroviral therapy:a meta-analysis[J].Clin Infect Dis, 2005, 41 (5) :713-720.

[16]POTTER M, ODUEYUNGBO A, YANG H, et al.Impact of HCV viral replication on CD4+T lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy[J].AIDS, 2010, 24 (12) :1857-1865.

施引文献

资源附件(0)

访问统计